A Study to Assess the Carriage of Pneumococci in Children Aged ≤8 Years, and Their Household Contacts
NCT03407690 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 280
Last updated 2019-08-29
Summary
Since the introduction of pneumococcal conjugate vaccines, this research group has conducted several carriage studies. These were at key points in the evolution of the pneumococcal immunisation schedule, with regard to the introduction of PCV7, the change to PCV13 and the impending change in number of doses of PCV13 given to infants. The last carriage study, conducted in 2015/16 identified interesting changes in carriage patterns which will further be explored by the current planned study.
Nasopharyngeal swabs and saliva swabs will be taken from healthy subjects and any pneumococci present will be cultured and serotyped using standard methods, as per our previous studies (Hussain et al., 2005; Flasche et al., 2011; van Hoek et al., 2014).
Conditions
- Immunization; Infection
Interventions
- OTHER
-
nasal swab
collection of nasal swab to allow carriage of pneumococci to be assessed
Sponsors & Collaborators
-
Public Health England
lead OTHER_GOV
Principal Investigators
-
Elizabeth Coates, PhD · Public Health England
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-02-14
- Primary Completion
- 2018-07-31
- Completion
- 2018-07-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Nasopharyngeal Carriage of S. Pneumoniae
NCT04460313 ·Status: RECRUITING ·Phase: NA
-
PCV7 in the Prevention of Nasopharyngeal Carriage of Vaccine Serotype (VT) Streptococcus Pneumoniae
NCT02133469 ·Status: COMPLETED ·Phase: NA
-
Evaluating Vaccine Responses in Healthy Infants Receiving Their Routine Primary Immunisation According to the Accelerated United Kingdom Schedule at 2, 3 and 4 Months
NCT01425372 ·Status: COMPLETED
-
PCV13 Impact on Pneumococcal Nasopharyngeal Carriage Study
NCT05114902 ·Status: UNKNOWN
-
Long-term Impact of Pneumococcal Conjugate Vaccine on Carriage
NCT00294021 ·Status: COMPLETED
-
Study Evaluating the Effiacy of a 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in Adults
NCT00744263 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Pneumococcal Vaccine on Nasopharyngeal Carriage
NCT01925222 ·Status: COMPLETED
-
Study Evaluating Antibody Response Of 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) 24 Months After Toddler Dose.
NCT01026038 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Immunogenicity Study of 20vPnC in Healthy Children 15 Months Through 17 Years of Age
NCT04642079 ·Status: COMPLETED ·Phase: PHASE3
-
PCV13 in Non-pregnant Papua New Guinean Women
NCT04183322 ·Status: COMPLETED
-
A Study Assessing 13-valent Pneumococcal Conjugate Vaccine in Healthy Chinese Infants and Young Children
NCT03574389 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of Fractional Doses of Pneumococcal Conjugate Vaccines on Immunogenicity and Carriage in Kenyan Infants
NCT03489018 ·Status: COMPLETED ·Phase: PHASE4
-
Indirect Effects of Pneumococcal Vaccine on Nasopharyngeal Carriage
NCT01311024 ·Status: COMPLETED
-
Study Evaluating the Nasopharyngeal Carriage in Healthy Children
NCT00768833 ·Status: COMPLETED
-
Paediatric Post Pneumococcal Conjugate Vaccine Nasopharyngeal Carriage Study
NCT04401488 ·Status: UNKNOWN
-
Effect of Two Versus Three Pneumococcal Conjugate Vaccinations
NCT00189020 ·Status: COMPLETED ·Phase: PHASE3
-
An Evaluation of PCV13 Vaccine Schedules, Comparing Impact of 2+1 vs 3+0 on Pneumococcal Carriage in Blantyre, Malawi
NCT04078997 ·Status: COMPLETED
-
Understanding Pneumococcal Carriage and Disease
NCT01996007 ·Status: COMPLETED
-
Study Evaluating 13-valent Pneumococcal Conjugate Vaccine (13vPnC) in Healthy Children Aged 15 Months to 17 Years
NCT00761631 ·Status: COMPLETED ·Phase: PHASE3
-
Study Evaluating 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants in Brazil
NCT00676091 ·Status: COMPLETED ·Phase: PHASE3
-
Study Evaluating the Impact of a 13-valent Pneumococcal Conjugate Vaccine on Nasopharyngeal Colonization
NCT00508742 ·Status: COMPLETED ·Phase: PHASE3
-
Study Evaluating the Impact of the 13-valent Pneumococcal Conjugate Vaccine (13vPnC) in Alaskan Native Children.
NCT00743652 ·Status: COMPLETED ·Phase: PHASE3
-
PREVENTING PNEUMOcoccal Disease Through Vaccination (Study 2)
NCT04974294 ·Status: UNKNOWN ·Phase: PHASE4
-
Study of Pneumococcal Carriage in RSV Bronchiolitis in Infants Aged 6 to 18 Months
NCT06722716 ·Status: NOT_YET_RECRUITING
-
Study Evaluating 13-valent Pneumococcal Conjugate Vaccine in Healthy Japanese Infants
NCT00574795 ·Status: COMPLETED ·Phase: PHASE3